(Reuters) – The U.S. Food and Drug Administration has approved the first rapid coronavirus diagnostic test, with a detection time of about 45 minutes, as the United States struggles to meet the demand for coronavirus testing.
The test’s developer, California-based molecular diagnostics company Cepheid, said on Saturday it had received an emergency use authorization from the FDA for the test, which will be used primarily in hospitals and emergency rooms. The company plans to begin shipping it to hospitals next week, it said.
The FDA confirmed its approval in a separate statement. It said the company intends to roll out the availability of its testing by March 30.
Under the current testing regime, samples must be sent to a centralized lab, where results can take days.
Read the full article here.